Seminal Plasma As a Diagnostic Fluid for Male Reproductive System Disorders

Overview

Journal Nat Rev Urol

Specialty Urology

Date 2014 Apr 9

PMID 24709963

Citations 78

Authors

Andrei P Drabovich

Punit Saraon

Keith Jarvi

Eleftherios P Diamandis

Affiliations

Soon will be listed here.

Abstract

Molecular biomarkers hold promise to advance the noninvasive diagnosis of male reproductive system disorders and facilitate the identification and management of these conditions through screening, early diagnosis and more accurate prognosis. Seminal plasma has great potential as a proximal fluid for protein biomarker discovery and as a clinical sample for noninvasive diagnostics. The seminal plasma proteome contains thousands of proteins and includes a large number of tissue-specific proteins that might accurately indicate a pathological process in the tissue of origin. Potential protein biomarkers for male reproductive system disorders are more abundant in seminal plasma than in blood serum or urine, and, therefore, are more easily identified and quantified in semen by mass spectrometry and other techniques. These methods have enabled elaboration of the composition of the seminal plasma proteome and the tissue specificity of seminal plasma proteins. Strategies have been developed to discover protein biomarkers in seminal plasma through integrated 'omics' approaches. Biomarkers of male infertility and prostate cancer are now emerging, and it is evident that seminal plasma has the potential to complement other diagnostic tools available in urology clinics.

Citing Articles

Association Between Zinc Levels and the Impact of Its Deficiency on Idiopathic Male Infertility: An Up-to-Date Review.

Zecevic N, Veselinovic A, Perovic M, Stojsavljevic A Antioxidants (Basel). 2025; 14(2).

PMID: 40002352 PMC: 11851646. DOI: 10.3390/antiox14020165.

Identification of important extracellular vesicle RNA molecules related to sperm motility and prostate cancer.

Zhang Y, Ding N, Xie S, Ding Y, Huang M, Ding X Extracell Vesicles Circ Nucl Acids. 2024; 2(2):104-126.

PMID: 39697534 PMC: 11648515. DOI: 10.20517/evcna.2021.02.

Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels.

Ferre-Giraldo A, Castells M, Sanchez-Herrero J, Lopez-Rodrigo O, de Rocco-Ponce M, Bassas L Int J Mol Sci. 2024; 25(18).

PMID: 39337607 PMC: 11432266. DOI: 10.3390/ijms251810122.

Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy: A Pilot Study.

Lakpour N, Sadeghi M, Jafarzadeh N, Henkel R, Hajiparvaneh A, Fathi Z J Reprod Infertil. 2024; 25(1):3-11.

PMID: 39157284 PMC: 11330202. DOI: 10.18502/jri.v25i1.15193.

Exposome Profiling of Environmental Pollutants in Seminal Plasma and Novel Associations with Semen Parameters.

Wu H, Kalia V, Manz K, Chillrud L, Dishon N, Jackson G Environ Sci Technol. 2024; 58(31):13594-13604.

PMID: 39053901 PMC: 11308511. DOI: 10.1021/acs.est.3c10314.

References

Baker M, Naumovski N, Hetherington L, Weinberg A, Velkov T, Aitken R . Head and flagella subcompartmental proteomic analysis of human spermatozoa. Proteomics. 2012; 13(1):61-74. DOI: 10.1002/pmic.201200350. View

Liu M, Hu Z, Qi L, Wang J, Zhou T, Guo Y . Scanning of novel cancer/testis proteins by human testis proteomic analysis. Proteomics. 2013; 13(7):1200-10. DOI: 10.1002/pmic.201200489. View

Heshmat S, Mullen J, Jarvi K, Soosaipillai A, Diamandis E, Hamilton R . Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia. J Urol. 2008; 179(3):1077-80. DOI: 10.1016/j.juro.2007.10.070. View

Chung C, Kanetsky P, Wang Z, Hildebrandt M, Koster R, Skotheim R . Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet. 2013; 45(6):680-5. PMC: 3723930. DOI: 10.1038/ng.2634. View

Yang L, Nyalwidhe J, Guo S, Drake R, John Semmes O . Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics. 2011; 10(6):M110.007294. PMC: 3108840. DOI: 10.1074/mcp.M110.007294. View

Yamakawa K, Yoshida K, Nishikawa H, Kato T, Iwamoto T . Comparative analysis of interindividual variations in the seminal plasma proteome of fertile men with identification of potential markers for azoospermia in infertile patients. J Androl. 2007; 28(6):858-65. DOI: 10.2164/jandrol.107.002824. View

Wang J, Wang J, Zhang H, Shi H, Ma D, Zhao H . Proteomic analysis of seminal plasma from asthenozoospermia patients reveals proteins that affect oxidative stress responses and semen quality. Asian J Androl. 2009; 11(4):484-91. PMC: 3735302. DOI: 10.1038/aja.2009.26. View

Wang Q, Chaerkady R, Wu J, Hwang H, Papadopoulos N, Kopelovich L . Mutant proteins as cancer-specific biomarkers. Proc Natl Acad Sci U S A. 2011; 108(6):2444-9. PMC: 3038743. DOI: 10.1073/pnas.1019203108. View

Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

10.

Wu C, MacLeod I, Su A . BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 2012; 41(Database issue):D561-5. PMC: 3531157. DOI: 10.1093/nar/gks1114. View

11.

Simpson A, Caballero O, Jungbluth A, Chen Y, Old L . Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005; 5(8):615-25. DOI: 10.1038/nrc1669. View

12.

Tanaka M, Kishi Y, Takanezawa Y, Kakehi Y, Aoki J, Arai H . Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett. 2004; 571(1-3):197-204. DOI: 10.1016/j.febslet.2004.06.083. View

13.

Li J, Liu F, Liu X, Liu J, Zhu P, Wan F . Mapping of the human testicular proteome and its relationship with that of the epididymis and spermatozoa. Mol Cell Proteomics. 2010; 10(3):M110.004630. PMC: 3047158. DOI: 10.1074/mcp.M110.004630. View

14.

Andrade-Rocha F . Assessment of increased desquamation of epididymal epithelial cells in semen of men as a predictor of acute epididymitis. Urol J. 2011; 8(4):320-2. View

15.

Coppola M, Klotz K, Kim K, Cho H, Kang J, Shetty J . SpermCheck Fertility, an immunodiagnostic home test that detects normozoospermia and severe oligozoospermia. Hum Reprod. 2010; 25(4):853-61. PMC: 2839906. DOI: 10.1093/humrep/dep413. View

16.

Diamandis E . Prostate-specific Antigen: Its Usefulness in Clinical Medicine. Trends Endocrinol Metab. 2008; 9(8):310-6. DOI: 10.1016/s1043-2760(98)00082-4. View

17.

Dohle G, Elzanaty S, van Casteren N . Testicular biopsy: clinical practice and interpretation. Asian J Androl. 2011; 14(1):88-93. PMC: 3735160. DOI: 10.1038/aja.2011.57. View

18.

Martinez-Prado E, Camejo Bermudez M . Expression of IL-6, IL-8, TNF-alpha, IL-10, HSP-60, anti-HSP-60 antibodies, and anti-sperm antibodies, in semen of men with leukocytes and/or bacteria. Am J Reprod Immunol. 2010; 63(3):233-43. DOI: 10.1111/j.1600-0897.2009.00786.x. View

19.

Taylor B, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver B . Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. PMC: 3198787. DOI: 10.1016/j.ccr.2010.05.026. View

20.

Krieger J, Ross S, Riley D . Chronic prostatitis: epidemiology and role of infection. Urology. 2003; 60(6 Suppl):8-12; discussion 13. DOI: 10.1016/s0090-4295(02)02294-x. View